Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organigram Hlds Inc (NQ: OGI )

1.580 -0.070 (-4.24%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Organigram Hlds Inc

< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Pure-Play Licensed Producers Pot Stock Index Declined 12.6% In April
Our Canadian Pure-Play LP Pot Stock Index was +4.2% last week and, while -12.6% in April, is still +42% YTD. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Week In Cannabis: PA, MD, Big Tobacco, GTI, Sundial, MedMen, Earnings, Financings And More
Cannabis stocks traded mostly in the green this week, as we got into earnings season. “While there were a lot of companies reportin... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From April 29, 2021
GAINERS: RIV Capital (OTC: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Philip Morris Ponders Joining Booming Cannabis Space
The Swiss-American multinational Philip Morris International Inc. (NYSE: PM... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Q2 Financials: Downward Trend Continues
Organigram announced its results for the Q2 2021 period ended February 28, 2021 and, like those of Q1, they were dismal across the board. 
Via Talk Markets
Organigram Reports Q2 Results: What Cannabis Stock Investors Need To Know
Organigram Holdings Inc. (NASDAQ:OGI) (TSX:... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From April 27, 2021
GAINERS: Invictus MD Strategies (OT... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Pure-Play LP Pot Stock Index Was Flat Last Week - Remains Up 36.7% YTD
There was marginal price movement in the index last week (Aurora was the exception as it was up 6.0%). 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From April 23, 2021
GAINERS: Tetra Bio Pharma (OTC: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why This Organigram Analyst Says It's A Good Time To Buy Cannabis Stock
Cannabis company Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) posted second-quarter earnings last week, with gross revenue dropping 29% year-over-year to around CA$19.3... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Expands Edison Cannabis Co. Dried Flower Portfolio with Two New High THC Strains: GMO Cookies and MAC-1
From Organigram Holdings Inc.
Via Business Wire
Creating New Strains Of Cannabis Essential To Cultivators For Introducing New Products With Higher THC Levels
Via FinancialNewsMedia
Topics Cannabis
Exposures Cannabis
OrganiGram Holdings (OGI) Q2 2021 Earnings Call Transcript
OGI earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Cannabis Stock Gainers And Losers From April 21, 2021
GAINERS: Wize Pharma (OTC: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why Canopy Growth, Aurora Cannabis, and HEXO Stocks All Popped Today
The U.S. Senate majority leader adds support to House of Representatives legislation that would make doing business easier for marijuana companies. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Is OrganiGram Holdings a Buy?
This under-the-radar Canadian pot grower is underwater. 
Via The Motley Fool
Topics Cannabis
Exposures COVID-19 Cannabis
Video: Cannabis Investing, Stock Picks With C3 Fund's Josh Kincaid, Vice Ventures' Catharine Dockery
With cannabis legalization poised to happen on a federal level sooner than later and continued growth of the cannabis industry, marijuana stocks ar... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why Aphria, OrganiGram Holdings, and Aurora Cannabis Rose Today
Consolidation is likely good for the burgeoning industry, but the marijuana sector remains speculative and immature. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, Apr. 19
The past, present and future of the Canadian cannabis sector based on a proprietary 25 stock index. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Week In Cannabis: New Mexico, Switzerland, Federal Legalization, Aphria, Organigram And More
In spite of some good news on the legalization front, cannabis stocks traded down this week, largely driven by lackluster earnings reports out of b... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Improving Quality of THC-Based Medications Proving to be Lucrative Path Cannabis Companies
Via FinancialNewsMedia
Topics Cannabis Law Enforcement
Exposures Cannabis Legal
Cannabis Stock Gainers And Losers From April 14, 2021
GAINERS: Claritas Pharmaceuticals (... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2021
Upgrades For Cardlytics Inc (NASDAQ:CDLX), Craig-Hallum upgraded the previous rating of Hold to Buy. For the fourth quarter, Cardlytics had an EPS of $0.05, compared to... 
Via Benzinga
How Growing Number Of Clinical Trials Are Influencing Growth Of The Cannabis Pharmaceuticals
Via FinancialNewsMedia
Topics Cannabis
Exposures Cannabis
10 Biggest Price Target Changes For Wednesday
JP Morgan raised Southwest Airlines Co. (NYSE: LUV) price target from $44 to $66. Southwest Airlines shares rose 1% to $63.79 in pre-market trading. Keybanc boosted Public... 
Via Benzinga
Have $1,000? Consider Buying These 2 Unstoppable Stocks
These futuristic stocks can yield solid returns in the coming years. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Why OrganiGram Holdings Stock Dropped Today
Investors initially reacted negatively to the Canadian cannabis company's quarterly results. 
Via The Motley Fool
Topics Cannabis
Exposures COVID-19 Cannabis
Why OrganiGram's Q2 Results Were So Ugly
There were multiple culprits behind the cannabis producer's top- and bottom-line deterioration. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers NovoCure (NASDAQ:NVCR) shares rose 63.02% to $215.0 during Tuesday's pre-market session. The company's market cap stands at $22.0 billion. Axcella Health (... 
Via Benzinga
Organigram Reports Second Quarter Fiscal 2021 Results
From Organigram Holdings Inc.
Via Business Wire
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.